Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone mass. [electronic resource]
Producer: 20120117Description: 34-45 p. digitalISSN:- 1108-7161
- Aged
- Alendronate -- administration & dosage
- Bone Density -- drug effects
- Bone Density Conservation Agents -- administration & dosage
- Bone Resorption -- drug therapy
- Bone and Bones -- drug effects
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Humans
- Hydroxycholecalciferols -- administration & dosage
- Osteoporosis, Postmenopausal -- diagnostic imaging
- Radiography
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.